Insider trades
Open-market buys and sales that US company officers, directors and 10% owners file, newest filing first.
| Trade type | ||||||||
|---|---|---|---|---|---|---|---|---|
DNA XSONM | Open-market sale | 25/06/26–25/06/30 | 25/06/30 | 866,916 sh2 trades | $1.45avg. | $1,256,317.46 | −100.0% | |
Michael C. MulicaDirector | DNA XSONM | Open-market sale | 25/04/23 | 25/04/25 | 27,818 sh | $1.45 | $40,336.1 | −27.5% |
James S. CassanoDirector | DNA XSONM | Open-market sale | 25/04/23 | 25/04/25 | 23,381 sh | $1.45 | $33,902.45 | −32.2% |
Charles BecherSEE REMARKS | DNA XSONM | Open-market sale | 25/04/23 | 25/04/25 | 31,326 sh | $1.45 | $45,422.7 | −33.3% |
Jeffrey WangDirector | DNA XSONM | Open-market sale | 25/04/23 | 25/04/25 | 4,478 sh | $1.45 | $6,493.1 | −17.4% |
Jack SteenstraDirector | DNA XSONM | Open-market sale | 25/04/23 | 25/04/25 | 23,381 sh | $1.45 | $33,902.45 | −32.2% |
DNA XSONM | Open-market sale | 25/04/23 | 25/04/25 | 11,634 sh | $1.45 | $16,869.3 | −27.3% | |
Michael C. MulicaDirector | DNA XSONM | Open-market sale | 24/11/13 | 24/11/14 | 2,559 sh | $3.28 | $8,393.52 | −4.5% |
James S. CassanoDirector | DNA XSONM | Open-market sale | 24/07/19 | 24/07/23 | 1,623 sh | $3.68 | $5,972.64 | −5.9% |
Jeffrey WangDirector | DNA XSONM | Open-market sale | 24/07/19 | 24/07/23 | 1,623 sh | $3.67 | $5,956.41 | −5.9% |
Jack SteenstraDirector | DNA XSONM | Open-market sale | 24/07/19 | 24/07/23 | 1,623 sh | $3.67 | $5,956.41 | −5.9% |
Michael C. MulicaDirector | DNA XSONM | Open-market sale | 24/06/21 | 24/06/24 | 36,016 sh | $0.69 | $24,851.04 | −7.8% |
James S. CassanoDirector | DNA XSONM | Open-market sale | 24/06/21 | 24/06/24 | 36,015 sh | $0.69 | $24,850.35 | −11.6% |
Jeffrey WangDirector | DNA XSONM | Open-market sale | 24/06/21 | 24/06/24 | 36,016 sh | $0.69 | $24,851.04 | −11.6% |
Jack SteenstraDirector | DNA XSONM | Open-market sale | 24/06/21 | 24/06/24 | 35,882 sh | $0.69 | $24,758.58 | −11.6% |
DNA XSONM | Open-market buy | 23/09/15 | 23/09/18 | 86,700 sh | $0.68 | $58,956 | No record | |
Alan B. HoweDirector | DNA XSONM | Open-market buy | 23/03/24 | 23/03/28 | 1,818 sh | $0.60 | $1,090.8 | +1.0% |